Doxorubicin-induced thiol-dependent alteration of cardiac mitochondrial permeability transition and respiration

Biochemistry (Moscow)

Volumn 71, Issue 2, 2006, Pages 194-199

  Oliveira, P J ^a   Santos, M S ^a   Wallace, K B ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Doxorubicin; Heart; Mitochondria; Oxidative stress

Indexed keywords

CARDIOLOGY; CELLS; DRUG PRODUCTS; OXIDATION; REDOX REACTIONS; TOXIC MATERIALS;

DOXORUBICIN; HEART; MITOCHONDRIA; OXIDATIVE STRESS;

PROTEINS;

ALPHA TOCOPHEROL; DOXORUBICIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL DERIVATIVE; UBIQUINONE;

ANIMAL; ARTICLE; CELL RESPIRATION; CHEMISTRY; DRUG EFFECT; HEART MITOCHONDRION; INTRACELLULAR MEMBRANE; MALE; METABOLISM; PERMEABILITY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CELL RESPIRATION; DOXORUBICIN; INTRACELLULAR MEMBRANES; MALE; MITOCHONDRIA, HEART; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SULFHYDRYL COMPOUNDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; UBIQUINONE; VITAMIN E;

EID: 33645277082     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S000629790602012X     Document Type: Article

References (28)

1. Hrdina, R., Gersl, V., Klimtova, I., Simunek, T., Macaackova, J., and Adamcova, M. (2000) Acta Medica, 43, 75-82.
2. Doroshow, J. H. (1983) Cancer Res., 43, 4543-4551.
3. Wallace, K. B. (2003) Pharmacol. Toxicol., 93, 105-115.
4. Demant, E. J. F. (1991) Biochem. Pharmacol., 41, 543-552.
5. Solem, L. E., Heller, L. J., and Wallace, K. B. (1996) J. Mol. Cell Cardiol., 28, 1023-1032.
6. Solem, L. E., Henry, T. R., and Wallace, K. B. (1994) ToxicoL Appl. Pharmacol., 129, 214-222.
7. Zhou, S., Starkov, A., Froberg, M. K., Leino, R. L., and Wallace, K. B. (2001) Cancer Res., 61, 771-777.
8. Zhou, S., Heller, L. J., and Wallace, K. B. (2001) Toxicol. Appl. Pharmacol., 175, 60-67.
9. Kowaltowski, A. J., and Vercesi, A. E. (1999) Free Rad. Biol. Med., 26, 463-471.
10. Sokolove, P. M., and Shinaberry, R. G. (1988) Biochem. Pharmacol., 37, 803-812.
11. Solem, L. E., and Wallace, K. B. (1993) Toxicol. Appl. Pharmacol., 121, 50-57.
12. Santos, D. L., Moreno, A. J. M., Leino, R. L., Froberg, M. K., and Wallace, K. B. (2002) Toxicol. Appl. Pharmacol., 185, 218-227.
13. Constantini, P., Chernyak, B. V., Petronilli, V., and Bernard!, P. (1996) J. Biol. Chem., 271, 6746-6751.
14. Brustovetsky, N., and Klingenberg, M. (1996) Biochemistry, 35, 8483-8488.
15. Zhou, S., Palmeira, C. M., and Wallace, K. B. (2001) Toxicol. Lett., 121, 151-157.
16. Bradford, M. M. (1976) Analyt. Biochem., 72, 248-254.
17. Estabrook, R. (1967) Meth. Enzymol., 10, 41-57.
18. Takada, M., Ikenoya, S., Yuzuriha, T., and Katayama, K. (1984) Meth. Enzymol., 105, 147-155.
19. Takayanagi, R., Takeshige, T., and Minakami, P. (1980) Biochem. J., 192, 853-860.
20. Wong, S. H.Y, Knight, J.A., Hopfer, S. M., Zaharia, O., Leach, C. N., and Sunderman, F. W (1987) Clin. Chem., 33, 214-220.
21. Fagian, M. M., Pereira-da-Silva, L., Martins, L S., and Vercesi, A. E. (1990) J. Biol. Chem., 265, 19955-19960.
22. Mimnaugh, E. G., Trush, M. A., and Gram, T. E. (1983) Cancer Treat. Rep., 67, 731-733.
23. Halestrap, A. P., Woodfield, K.-Y., and Connern, C. P. (1997) J. Biol. Chem., 272, 3346-3354.
24. McStay, G. P., Clarke, S. J., and Halestrap, A. P. (2002) Biochem. J., 367, 541-548.
25. Kokoszka, J. E., Waymire, K. G., Levy, S. E., Sligh, J. E., Cai, J., Jones, D. P., MacGregor, G. R., and Wallace, D. C. (2004) Nature, 427, 461-465.
26. Broekemeier, K. M., Dempsey, M. E., and Pfeiffer, D. R. (1989) J. Biol. Chem., 264, 7826-7830.
27. Balijepalli, S., Annepu, J., Boyd, M. R., and Ravindranath, V. (1999) Neurosci. Lett., 272, 203-206.
28. Connern, C. P., and Halestrap, A. P. (1994) Biochem. J., 302, 321-324.